Viome and Scripps Research Partner to develop first at-home RNA screening test to prevent colon cancer before it strikes
Business Announcement
Updates every hour. Last Updated: 28-Dec-2025 06:11 ET (28-Dec-2025 11:11 GMT/UTC)
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today announced a strategic partnership to develop and clinically validate the first at-home RNA test designed to detect precancerous colon polyps, enabling early prevention of colorectal cancer.
While artificial intelligence is transforming healthcare in technologically advanced nations, it has yet to make a meaningful impact on health services in less developed countries of the Global South.
Studying how cells work inside a living body is one of the most powerful ways to understand health and disease. However, looking deep inside live tissue is extremely challenging, especially when trying to see very small structures like mitochondria the tiny engines inside cells that produce energy and help regulate many important biological functions. These structures are constantly moving and changing, so scientists need imaging tools that can capture them in action, clearly and without harming the animal.
Using a high-throughput fluorescence microscopy system and machine learning algorithms, oxidative stress-related changes in protein localization have been mapped by researchers from Japan. Furthermore, a comprehensive database called Localizatome has been developed by compiling the subcellular protein localization data of 10,287 human proteins. This database provides information on both the steady-state subcellular localization of proteins and dynamic localization changes that occur in response to oxidative stress.
Researchers from the universities of Basel and Zurich have used a historical specimen from UZH’s Medical Collection to decode the genome of the virus responsible for the 1918–1920 influenza pandemic in Switzerland. The genetic material of the virus reveals that it had already developed key adaptations to humans at the outset of what became the deadliest influenza pandemic in history.